Latar belakang. Sebagian kasus neuromuskular dapat ditegakkan berdasarkan klinis. Pemeriksaan penunjang, pemeriksaan imunologi dan analisis genetik sangat penting diperiksa untuk memastikan diagnosis. Ini merupakan penelitian pertama mengenai prevalensi penyakit neuromuskular di Indonesia.Tujuan. Mengetahui prevalensi, spektrum klinis, dan gambaran neurofisiologi kasus neuromuskular di RSCM periode Januari – Desember 2017.Metode. Penelitian ini bersifat retrospektif dari Januari – Desember 2017.Hasil. Di tahun 2017 terdapat 179 pasien (usia 1 bulan – 18 tahun) yang dirujuk untuk dilakukan pemeriksaan elektromiografi, dan 130 pasien memenuhi kriteria diagnostik penyakit neuromuskular. Dari seluruh pasien kelainan neuromuskular yang sering ditemukan berturut-turut adalah neuropati perifer (22,2%), Duchenne muscular dystrophy (15,6%), brachialis plexus injury (15,2%), Bell’s palsy (7,6%), Erb Palsy (6,1%), chronic inflamatory demyelinating polyneuropathy (5,4 %), spinal muscular atrophy type 1 (4,6 %), spinal muscular atrophy type 2 (3,8%), miastenia gravis okular (3,8%), Limb Girdle muscular dystrophy (3,1%), sindrom Guillain Barre (3,1%), sindrom Guillain Barre-tipe acute motor axonal neuropathy (2,3%), sindrom Guillain Barre-tipe acute motor-sensory axonal neuropathy (1,5%), miastenia gravis umum (1,5%), Charcot Marie tooth (1,5%), miotonia kongenital (1,5%), dan miositis viral akut (1,5%). Kesimpulan. Prevalensi kelainan neuromuskular anak RSCM sebesar 2,6 % dari seluruh pasien yang dilakukan datang ke poli saraf anak. Lima terbanyak kelainan neuromuskular adalah neuropati perifer, Ducchenne Muscular dystrophy, spinal muskular atrofi, sindrom Guillain Barre, dan chronic inflamatory demyelinating polyneuropathy.
Background Asphyxia neonatorum may result in multiorgandysfunction including renal involvement. There is no consensuson the determination of acute kidney injury (AKI) in neonatesmaking establishment of the diagnosis and its managementbecomes difficult. The Acute Kidney Injury Network (AKIN)recommends AKI criteria based on increased serum creatininelevel and reduced urine output.Objectives To identify the prevalence of AKI in asphyxiatedneonates using the AKIN criteria, to compare the difference ofAKI stages, and the glomerular filtration rates (GFR) betweenmoderate and severe asphyxia.Methods This was a cross-sectional analytical study conductedbetween July 2012 and January 2013. Subjects were all asphyxiatedneonates (Apgar score < 7 at fifth minute) with gestational age of>35 weeks delivered and hospitalized in Cipto MangunkusumoHospital and Koja District Hospital, Jakarta, Indonesia.Glomerular filtration rate was calculated using the componentsof urine creatinine, serum creatinine, and urine output; whileAKI stages were determined according to AKIN criteria. Urinaryoutput was measured via urethral catheterization.Results Of 94 subjects, there were 70 neonates with moderateand 24 neonates with severe asphyxia, with the prevalence of AKIwas 63%. Twenty one out of 24 neonates with severe asphyxiaexperienced AKI, while neonates with moderate asphyxia whoexperienced AKI was 38 out of 70 subjects (54%). Two third ofneonates with severe asphyxia who experienced AKI had stage3 of AKI. More severe AKI stages and lower median GFR werefound in neonates with severe compared to moderate asphyxia(P<0.001) .Conclusion The prevalence of AKI in neonatal asphyxia is high(63%). The more severe degree of neonatal asphyxia, the moresevere AKI stage and the lower median GFR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.